SENORES PHARMACEUTICALS
|
The Current P/B Ratio of SENORES PHARMACEUTICALS is 6.27.
| Share Price | ₹1,269.0 | Jun 25,2026 |
| Market Cap | ₹5,849.9 Cr | |
| Book Value | ₹933.6 Cr | Mar2026 - Consolidated Results |
| Price/Book | 6.27x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of SENORES PHARMACEUTICALS
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹5,849.9 Cr] as on Jun 25,2026
(/) Book Value [ ₹933.6 Cr] based on Mar2026 - Consolidated Results
(=) P/B Ratio [ 6.27x ]
Thus, for SENORES PHARMACEUTICALS , the investors are currently willing to pay '6.27 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of SENORES PHARMACEUTICALS !
The chart below summarizes the trend in P/B Ratio of SENORES PHARMACEUTICALS over the last five years.
Historical PB (Price/Book ) ratio chart of SENORES PHARMACEUTICALS
PB Ratio Performance Analysis for SENORES PHARMACEUTICALS
- SENORES PHARMACEUTICALS 's p/b ratio for fiscal years ending Mar2025 to Mar2022 averaged 0.84x.
- SENORES PHARMACEUTICALS 's operated at median p/b ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 4 fiscal years, SENORES PHARMACEUTICALS 's p/b ratio peaked in Mar2025 at 3.35x.
- SENORES PHARMACEUTICALS 's p/b ratio hit its five-year low in Mar2024 of 0x.
How does SENORES PHARMACEUTICALS 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| SENORES PHARMACEUTICALS | 933.60 | 6.27 | 5,849.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 83,570.10 | 5.35 | 446,792.0 |
| DIVIS LABORATORIES LTD | 16,761.00 | 10.63 | 178,152.0 |
| TORRENT PHARMACEUTICALS LTD | 8,388.43 | 18.23 | 152,915.0 |
| CIPLA LTD | 34,369.40 | 3.39 | 116,354.0 |
| DR REDDYS LABORATORIES LTD | 37,891.50 | 2.97 | 112,681.0 |
| MANKIND PHARMA LTD | 16,300.30 | 6.23 | 101,632.0 |
| LUPIN LTD | 22,448.30 | 4.77 | 107,091.0 |
| ZYDUS LIFESCIENCES LTD | 27,111.40 | 4.05 | 109,875.0 |
| AUROBINDO PHARMA LTD | 37,891.00 | 2.36 | 89,468.4 |
| LAURUS LABS LTD | 5,275.08 | 14.86 | 78,368.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs SENORES PHARMACEUTICALS 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.36x |
| Max industry PB | 18.23x |
| Median industry PB | 5.35x |
| Average industry PB | 7.19x |
You may also like the below Video Courses